Australia’s leading digital healthcare publisher

For over 45 years the Australian healthcare community has relied on Therapeutic Guidelines to provide an independent, evidence-based clinical resource. In the decades following the first Antibiotic guidelines release, we grew rapidly and became Australia’s leading not-for-profit healthcare publisher respected by clinicians at every stage of their career.

Partnership Program

Expert Groups

Guideline Development Process

Research Funding

Supporting the career journey of clinicians

As Australia’s leading clinical decision support resource, we assist clinicians, nationally and internationally, through their entire career journey. We are proud to be the first point of call for students, doctors in training, specialists, dentists, pharmacists, allied health professionals, and nurse practitioners.

Designed by clinicians for clinicians

Therapeutic Guidelines are regularly updated, based on the latest international literature, interpreted by Australia’s most respected experts, with input from an extensive network of general practitioners, pharmacists and other users.

Proudly Independent

Independence is an essential feature of Therapeutic Guidelines. Funded only by subscribers, meaning no grants, advertising, shareholders or sponsors. To protect and maintain independence, a strict conflict of interest policy is in place.

Evidence Based Processes

The relevance and strength of the scientific evidence for the effectiveness of any given treatment are fundamental to the development of the content in Therapeutic Guidelines. To make sure that the advice is clinically relevant and applicable, the information must be contextualised to reflect the reality of everyday clinical situations.
GUIDELINE DEVELOPMENT

An independent, evidence-based process

Learn More
EXPERT GROUPS

100’s of experts

Learn More
RESEARCH FUNDING

Partnering with the Australian General Practice Research Foundation

Learn More
PARTNERSHIP PROGRAM

Partnering to provide quality medical assets

Learn More